Annual Gross Profit
$29.75 M
+$1.46 M+5.15%
December 31, 2023
Summary
- As of February 7, 2025, AQST annual gross profit is $29.75 million, with the most recent change of +$1.46 million (+5.15%) on December 31, 2023.
- During the last 3 years, AQST annual gross profit has fallen by -$3.13 million (-9.53%).
- AQST annual gross profit is now -36.83% below its all-time high of $47.10 million, reached on December 31, 2017.
Performance
AQST Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$9.11 M
-$6.47 M-41.53%
September 30, 2024
Summary
- As of February 7, 2025, AQST quarterly gross profit is $9.11 million, with the most recent change of -$6.47 million (-41.53%) on September 30, 2024.
- Over the past year, AQST quarterly gross profit has increased by +$901.00 thousand (+10.98%).
- AQST quarterly gross profit is now -59.11% below its all-time high of $22.27 million, reached on September 30, 2017.
Performance
AQST Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$40.87 M
+$901.00 K+2.25%
September 30, 2024
Summary
- As of February 7, 2025, AQST TTM gross profit is $40.87 million, with the most recent change of +$901.00 thousand (+2.25%) on September 30, 2024.
- Over the past year, AQST TTM gross profit has increased by +$14.27 million (+53.63%).
- AQST TTM gross profit is now -26.46% below its all-time high of $55.58 million, reached on June 30, 2018.
Performance
AQST TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
AQST Gross Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.2% | +11.0% | +53.6% |
3 y3 years | -9.5% | +11.0% | +53.6% |
5 y5 years | -35.9% | +11.0% | +53.6% |
AQST Gross Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -17.0% | +5.2% | -41.5% | +69.3% | at high | +62.0% |
5 y | 5-year | -17.0% | +5.2% | -49.8% | +108.8% | at high | +62.0% |
alltime | all time | -36.8% | +5.2% | -59.1% | +108.8% | -26.5% | +233.6% |
Aquestive Therapeutics Gross Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $9.11 M(-41.5%) | $40.87 M(+2.3%) |
Jun 2024 | - | $15.57 M(+103.2%) | $39.97 M(+28.9%) |
Mar 2024 | - | $7.66 M(-10.1%) | $31.02 M(+4.3%) |
Dec 2023 | $29.75 M(+5.2%) | $8.53 M(+3.9%) | $29.75 M(+11.8%) |
Sep 2023 | - | $8.20 M(+23.9%) | $26.60 M(+5.4%) |
Jun 2023 | - | $6.62 M(+3.5%) | $25.24 M(-5.3%) |
Mar 2023 | - | $6.40 M(+19.0%) | $26.64 M(-5.9%) |
Dec 2022 | $28.29 M(-21.1%) | $5.38 M(-21.4%) | $28.29 M(-7.6%) |
Sep 2022 | - | $6.84 M(-14.8%) | $30.63 M(-6.3%) |
Jun 2022 | - | $8.02 M(-0.4%) | $32.68 M(-8.0%) |
Mar 2022 | - | $8.06 M(+4.5%) | $35.53 M(-0.9%) |
Dec 2021 | $35.84 M(+9.0%) | $7.71 M(-13.2%) | $35.84 M(+10.3%) |
Sep 2021 | - | $8.89 M(-18.3%) | $32.49 M(+12.5%) |
Jun 2021 | - | $10.88 M(+30.1%) | $28.89 M(-20.1%) |
Mar 2021 | - | $8.37 M(+91.8%) | $36.14 M(+9.9%) |
Dec 2020 | $32.88 M | $4.36 M(-17.4%) | $32.88 M(-13.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | $5.28 M(-70.9%) | $38.15 M(-6.1%) |
Jun 2020 | - | $18.14 M(+255.2%) | $40.64 M(+44.0%) |
Mar 2020 | - | $5.11 M(-47.0%) | $28.22 M(-12.5%) |
Dec 2019 | $32.25 M(-30.6%) | $9.63 M(+23.8%) | $32.25 M(-7.0%) |
Sep 2019 | - | $7.78 M(+36.2%) | $34.66 M(+0.3%) |
Jun 2019 | - | $5.71 M(-37.5%) | $34.56 M(-8.6%) |
Mar 2019 | - | $9.14 M(-24.1%) | $37.80 M(-18.6%) |
Dec 2018 | $46.44 M(-1.4%) | $12.04 M(+56.8%) | $46.44 M(+13.3%) |
Sep 2018 | - | $7.67 M(-14.3%) | $40.98 M(-26.3%) |
Jun 2018 | - | $8.96 M(-49.6%) | $55.58 M(+5.6%) |
Mar 2018 | - | $17.77 M(+170.1%) | $52.62 M(+11.7%) |
Dec 2017 | $47.10 M(+33.0%) | $6.58 M(-70.4%) | $47.10 M(+16.2%) |
Sep 2017 | - | $22.27 M(+271.0%) | $40.52 M(+122.0%) |
Jun 2017 | - | $6.00 M(-51.0%) | $18.25 M(+49.0%) |
Mar 2017 | - | $12.25 M | $12.25 M |
Dec 2016 | $35.41 M | - | - |
FAQ
- What is Aquestive Therapeutics annual gross profit?
- What is the all time high annual gross profit for Aquestive Therapeutics?
- What is Aquestive Therapeutics annual gross profit year-on-year change?
- What is Aquestive Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Aquestive Therapeutics?
- What is Aquestive Therapeutics quarterly gross profit year-on-year change?
- What is Aquestive Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Aquestive Therapeutics?
- What is Aquestive Therapeutics TTM gross profit year-on-year change?
What is Aquestive Therapeutics annual gross profit?
The current annual gross profit of AQST is $29.75 M
What is the all time high annual gross profit for Aquestive Therapeutics?
Aquestive Therapeutics all-time high annual gross profit is $47.10 M
What is Aquestive Therapeutics annual gross profit year-on-year change?
Over the past year, AQST annual gross profit has changed by +$1.46 M (+5.15%)
What is Aquestive Therapeutics quarterly gross profit?
The current quarterly gross profit of AQST is $9.11 M
What is the all time high quarterly gross profit for Aquestive Therapeutics?
Aquestive Therapeutics all-time high quarterly gross profit is $22.27 M
What is Aquestive Therapeutics quarterly gross profit year-on-year change?
Over the past year, AQST quarterly gross profit has changed by +$901.00 K (+10.98%)
What is Aquestive Therapeutics TTM gross profit?
The current TTM gross profit of AQST is $40.87 M
What is the all time high TTM gross profit for Aquestive Therapeutics?
Aquestive Therapeutics all-time high TTM gross profit is $55.58 M
What is Aquestive Therapeutics TTM gross profit year-on-year change?
Over the past year, AQST TTM gross profit has changed by +$14.27 M (+53.63%)